FDA Clearance Tracker · K260224
MySOZO Software version 6.1.0.1 (SW version 6.1.0.1)
Last checked: Nov 19, 2026Latest source record: Aug 17, 2026 (this decision)Source: openFDAMethods & limitations
Decided
Aug 17, 2026
Substantially Equivalent
Time to decision
203 days
Received Jan 26, 2026. Calendar days, including time FDA spent waiting on the applicant.
Pathway
510(k)
Traditional
Device class
Class II
The decision
- FDA number
- K260224
- Device name
- MySOZO Software version 6.1.0.1 (SW version 6.1.0.1)
- Applicant
- ImpediMed Limited
- Applicant location
- Lindfield, AU
- Received
- Jan 26, 2026
- Decided
- Aug 17, 2026
- Decision
- Substantially Equivalent
- Submission type
- Traditional
Device type
- Device type
- Plethysmograph, Impedance (DSB)
- Device class
- Class II
- Regulation
- 21 CFR 870.2770
- Specialty
- Cardiology
How new is this?
These are facts about FDA's records. They are not a judgment about the device.
- It is not the first decision under product code DSB. The earliest in FDA's data is K772092, decided Nov 18, 1977.
- It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.
Source documents
- FDA database record for K260224
- 510(k) summary (PDF) · FDA posts these some weeks after the decision, so a recent one may not open yet.
The predicate devices this clearance relied on are named in the summary document. We do not extract them yet.
Other decisions for ImpediMed Limited
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
K253224 · Decided Jan 28, 2026 · 121 days after receipt
Device type: Monitor, Extracellular Fluid, Lymphedema, Extremity (OBH) · Cardiology
- SOZO Pro510(k)
K232089 · Decided Oct 17, 2023 · 96 days after receipt
Device type: Plethysmograph, Impedance (DSB) · Cardiology
- SOZO Pro510(k)
K230530 · Decided May 4, 2023 · 66 days after receipt
Device type: Monitor, Extracellular Fluid, Lymphedema, Extremity (OBH) · Cardiology
5 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.